Arthur Tzianabos

Director & Interim Executive Chair

Director & Interim Executive Chair at Stoke Therapeutics, Inc., filing insider transactions on 2026-03-10.

Total Purchases

—

0 transactions

Total Sales

$174K

1 transaction

Companies Traded

1 total filings

Active Since

2026-03-10

Last: 2026-03-10

Companies

Stoke Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-10	STOK	Sale	4,355	$40.00	$174K	31.3K	SEC ↗